Cornell University - Visit www.cornell.edu Kirby Research Group at Cornell: Microfluidics and Nanofluidics : - Home College of Engineering - visit www.engr.cornell.edu Cornell University - Visit www.cornell.edu
Cornell University, College of Engineering Search Cornell
News Contact Info Login
Cornell Micro/Nanofluidics Laboratory
The Micro/Nanofluidics Laboratory, directed by Professor Brian Kirby, is a research group in the Sibley School of Mechanical and Aerospace Engineering at Cornell University devoted to research on understanding and application of micro- and nanofluidic systems. Microfluidics and nanofluidics describe fluid-mechanical regimes and devices defined by the length scale of the flow channels, the techniques for making the devices, and the dominant physics.

Features
Kirby Lab microfluidics nanofluidics Circulating tumor cell capture
Enabling personalized chemotherapeutics for cancer patients
Kirby Lab microfluidics nanofluidics Student blog
Keeping up with Kirbylab
Kirby Lab microfluidics for processing nanofibers Weaving the next generation of nanofiber textiles
How microfluidic flow control enables materials characterization in nanofibers
Kirby Lab microfluidics nanofluidics algae biodiesel Dielectric characterization
Developing process control for algae biofuel feedstocks
Kirby Lab microfluidics nanofluidics lab on a chip Microbioanalytical devices
The lab-on-a-chip paradigm
Kirby Lab microfluidics nanofluidics Environmental sampling
Detecting viral pathogens in complex water systems
Microfluidics in Cornell College of
Engineering.  Micro/Nanofluidics Laboratory, Bill Polacheck and Sarah Lee in
the lab
Bill and Sarah at our microbial cell culture facility, summer 2007, working on designing biomaterials that allow study of chondrocyte mechanotransduction.
A circulating tumor cell captured by a GEDI device (refs here and here) from peripheral blood of a castrate-resistant prostate cancer patient shows evidence of the TMPRSS2:ERG gene fusion. Top: DAPI stain of circulating tumor cell nucleus. Bottom: ERG protein upregulation imaged with immunofluorescence is indicative of gene fusion.
A schematic of the size-dependent trajectories and surface collisions used in geometrically enhanced differential immunocapture, which we use to capture circulating tumor cells from the peripheral blood of castrate-resistant prostate cancer patients.
Correlation between circulating tumor cell counts with Veridex CellSearch compared with our GEDI microdevices shows markedly increased capture (ref here).